# Analysis on Pharmaceutical Formularies and Rebates

Comments on the research by Kate Ho and Robin S. Lee

- **Source:** [Econometrica](https://onlinelibrary.wiley.com/journal/14680262)
- **Published:** 2026-06-08
- **Topic:** [Business](https://brifing.si/c/business)
- **Original article:** <https://onlinelibrary.wiley.com/doi/10.3982/ECTA23938?af=R>
- **On Brifing:** https://brifing.si/s/f73e620c-5289-4765-a64f-4e5faca133bb

## Introduction

Kate Ho and Robin S. Lee's study titled 'Fisher-Schultz Lecture: Contracting Over Pharmaceutical Formularies and Rebates' has sparked a significant discussion in the field of health economics. This research examines the dynamics of contracts in the pharmaceutical industry.

## Research Objective

The study analyzes the economic impacts of contracts on pharmaceutical formularies and rebates. The effects of these processes on both producers and consumers are thoroughly examined.

## Methodology

The research was conducted using econometric models. These models aim to measure the effects of pharmaceutical contracts on pricing and access.

## Findings

The study's findings show that pharmaceutical rebates can be beneficial for both producers and consumers. However, it also emphasizes the need for regulation in these processes.

## Discussion

The research is seen as an important step in better understanding the dynamics of contracts in the pharmaceutical industry. These findings are also guiding for policymakers.

## Conclusion

Kate Ho and Robin S. Lee's study is an important resource for understanding the economic impacts of contracts on pharmaceutical formularies and rebates. This research can inspire new studies in the field of health economics.

## Sources covering this story

- https://onlinelibrary.wiley.com/doi/10.3982/ECTA23938?af=R — 

---

_Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._